Skip to search formSkip to main contentSkip to account menu

tritoqualine

Known as: 4,5,6-triethoxy-7-amino-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)phthalide, 7-amino-4,5,6-triethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)iso quinolin-5-yl)-1(3H)-isobenzofuranone, tritoqualin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
SummaryThe effect of orally administered histidine decarboxylase inhibitor on liver function tests and histological appearance as… 
Review
1988
Review
1988
The role of histamine in hypersensitivity reactions justifies the use of antagonistic medication. The symptomatic action of the… 
1987
1987
Tritoqualine (TRQ) was previously reported to suppress enzyme leakage and lipid peroxidation induced by carbon tetrachloride in… 
1987
1987
Treatment of rats with histamine releaser compound 48/80 caused changes in blood leukocyte populations. An increased number of… 
1986
1986
Since tritoqualine (TRQ) is effective in suppressing the increase of serum transaminases in acute hepatic injured rats induced by… 
1985
1985
Tritoqualine (TRQ), used clinically as an antiallergic drug, did not inhibit histidine decarboxylase activity (HDC, EC. 4.1.1.22… 
1985
1985
Tritoqualine (TRQ) administered at doses of 100 or 200 mg/kg, perorally, had a preventive effect on the liver injury in rats… 
1985
1985
Rats were treated with CCl4 for 12 weeks to induce chronic liver injury. An administration of tritoqualine (TRQ) to rats was…